News | New Evidence on Vitamin B12 Supplements: Form May Matter More Than Dose
A newly published scientific review suggests that the form of vitamin B12 may matter more than the amount taken. Comparing natural and synthetic forms in terms of absorption, physiological effects and clinical impact, the review indicates that methylcobalamin may offer advantages over the more common synthetic form, cyanocobalamin, for some people. It also notes that vitamin B12 deficiency remains easily overlooked in clinical practice.
Vitamin B12 is an essential water-soluble vitamin found mainly in animal-based foods. It occurs in three forms: cyanocobalamin, methylcobalamin and adenosylcobalamin. Deficiency can cause megaloblastic anemia, neuropathy and pregnancy complications. Although both supplements and dietary intake can raise serum B12 levels in healthy people, diet alone is often insufficient once a clear deficiency disorder develops, and medication or nutritional supplementation is still required.
Published in the medical journal Cureus, the review examined vitamin B12 absorption and metabolism in detail. Dietary B12 is usually protein-bound and released through pepsin hydrolysis in the stomach. It then binds to haptocorrin for protection from gastric acid. In the duodenum, pancreatic enzymes break down haptocorrin, allowing free B12 to bind to intrinsic factor secreted by gastric parietal cells. It is absorbed through a receptor-mediated process in the distal ileum, then transported in the bloodstream by transcobalamin II to bone marrow and other tissues.
Physiologically, vitamin B12 is a key cofactor in one-carbon metabolism. It supports conversion of homocysteine to methionine and regeneration of tetrahydrofolate, making it essential for DNA synthesis, red blood cell production and energy metabolism. It is also an important coenzyme for methylmalonyl-CoA mutase and is closely linked to fat and protein metabolism and the integrity of nerve myelin.
When B12 is deficient, DNA synthesis is impaired and red blood cell nuclei fail to mature properly, producing enlarged immature red blood cells and ultimately megaloblastic anemia. Clinical effects can include peripheral neuropathy and cognitive impairment. Early symptoms include glossitis, mild yellowing of the skin, weight loss, numbness or tingling in the limbs and vision changes. Vitamin B12 deficiency during pregnancy is also associated with an increased risk of neural tube defects such as spina bifida.
The review also noted that B12 supplementation has improved symptoms in some people with depression and may enhance the effects of antidepressants. Although mechanistic studies suggest that abnormal one-carbon metabolism, elevated homocysteine and mitochondrial dysfunction may contribute to neurodegenerative disease, there is currently no direct evidence of a clear causal relationship between B12 deficiency and Alzheimer's disease.
In severe deficiency, disrupted methylmalonyl-CoA metabolism can cause demyelination of the lateral and posterior columns of the spinal cord, resulting in subacute combined degeneration. B12's role in immune regulation is also receiving attention: it may increase lymphocyte numbers and activity and suppress systemic inflammation, but the clinical significance remains unconfirmed. Findings on its potential role in COVID-19 are inconsistent and do not establish a clear benefit.
Older adults, vegans and vegetarians are at high risk of B12 deficiency. Atrophic gastritis, pernicious anemia, Crohn's disease, celiac disease, a history of gastrointestinal surgery, long-term alcohol use and Sjögren's syndrome also increase risk. Long-term use of metformin, proton pump inhibitors, H2-receptor antagonists and oral contraceptives may lower B12 levels.
Data show that about 3% of people aged 20 to 39 have B12 deficiency, rising to 6% among those over 60. Because symptoms vary and serum levels differ widely, the review emphasizes testing to confirm diagnosis. Serum B12 below 150 pg/mL is generally considered deficient. Most cases result not from inadequate intake but from impaired absorption or utilization.
Dietary sources rich in B12 include beef liver, fortified yeast, salmon, Greek yogurt, eggs and clams. Beef liver contains about 71 micrograms per serving, compared with about 0.5 micrograms in an egg. Recommended daily intake is 2.4 micrograms for adults, increasing to 2.6 micrograms during pregnancy and 2.8 micrograms while breastfeeding.
When comparing supplement forms, the review noted that B12 from either food or supplements must ultimately be converted into the active forms methylcobalamin or adenosylcobalamin. Cyanocobalamin, the most common synthetic supplement form, must first have its cyano group removed before activation, and mutations in metabolic pathways may impair this conversion in some people.
Evidence suggests that cyanocobalamin is stored in the liver at lower levels than natural forms and may be excreted in urine at a higher rate. Inadequate conversion by the liver may adversely affect neurological health. The methyl group carried by methylcobalamin may also promote serotonin production and offer some brain protection. Although current research is not sufficient for definitive conclusions, the overall evidence suggests that methylcobalamin may have better bioavailability and stability than cyanocobalamin, particularly for people with absorption problems or impaired methylation.
The authors emphasized that while both forms can effectively raise serum B12, direct comparative evidence on clinical outcomes remains limited. Future studies should clarify how different supplement forms affect long-term neuroprotection and disease prevention.
The review recommends greater B12 screening among older adults, vegetarians and people with certain gastrointestinal disorders. Early intervention may help prevent irreversible neurological and hematological damage.
News | New Evidence on Vitamin B12 Supplements: Form May Matter More Than Dose
News | New Evidence on Vitamin B12 Supplements: Form May Matter More Than Dose
A newly published scientific review suggests that the form of vitamin B12 may matter more than the amount taken. Comparing natural and synthetic forms in terms of absorption, physiological effects and clinical impact, the review indicates that methylcobalamin may offer advantages over the more common synthetic form, cyanocobalamin, for some people. It also notes that vitamin B12 deficiency remains easily overlooked in clinical practice.
Vitamin B12 is an essential water-soluble vitamin found mainly in animal-based foods. It occurs in three forms: cyanocobalamin, methylcobalamin and adenosylcobalamin. Deficiency can cause megaloblastic anemia, neuropathy and pregnancy complications. Although both supplements and dietary intake can raise serum B12 levels in healthy people, diet alone is often insufficient once a clear deficiency disorder develops, and medication or nutritional supplementation is still required.
Published in the medical journal Cureus, the review examined vitamin B12 absorption and metabolism in detail. Dietary B12 is usually protein-bound and released through pepsin hydrolysis in the stomach. It then binds to haptocorrin for protection from gastric acid. In the duodenum, pancreatic enzymes break down haptocorrin, allowing free B12 to bind to intrinsic factor secreted by gastric parietal cells. It is absorbed through a receptor-mediated process in the distal ileum, then transported in the bloodstream by transcobalamin II to bone marrow and other tissues.
Physiologically, vitamin B12 is a key cofactor in one-carbon metabolism. It supports conversion of homocysteine to methionine and regeneration of tetrahydrofolate, making it essential for DNA synthesis, red blood cell production and energy metabolism. It is also an important coenzyme for methylmalonyl-CoA mutase and is closely linked to fat and protein metabolism and the integrity of nerve myelin.
When B12 is deficient, DNA synthesis is impaired and red blood cell nuclei fail to mature properly, producing enlarged immature red blood cells and ultimately megaloblastic anemia. Clinical effects can include peripheral neuropathy and cognitive impairment. Early symptoms include glossitis, mild yellowing of the skin, weight loss, numbness or tingling in the limbs and vision changes. Vitamin B12 deficiency during pregnancy is also associated with an increased risk of neural tube defects such as spina bifida.
The review also noted that B12 supplementation has improved symptoms in some people with depression and may enhance the effects of antidepressants. Although mechanistic studies suggest that abnormal one-carbon metabolism, elevated homocysteine and mitochondrial dysfunction may contribute to neurodegenerative disease, there is currently no direct evidence of a clear causal relationship between B12 deficiency and Alzheimer's disease.
In severe deficiency, disrupted methylmalonyl-CoA metabolism can cause demyelination of the lateral and posterior columns of the spinal cord, resulting in subacute combined degeneration. B12's role in immune regulation is also receiving attention: it may increase lymphocyte numbers and activity and suppress systemic inflammation, but the clinical significance remains unconfirmed. Findings on its potential role in COVID-19 are inconsistent and do not establish a clear benefit.
Older adults, vegans and vegetarians are at high risk of B12 deficiency. Atrophic gastritis, pernicious anemia, Crohn's disease, celiac disease, a history of gastrointestinal surgery, long-term alcohol use and Sjögren's syndrome also increase risk. Long-term use of metformin, proton pump inhibitors, H2-receptor antagonists and oral contraceptives may lower B12 levels.
Data show that about 3% of people aged 20 to 39 have B12 deficiency, rising to 6% among those over 60. Because symptoms vary and serum levels differ widely, the review emphasizes testing to confirm diagnosis. Serum B12 below 150 pg/mL is generally considered deficient. Most cases result not from inadequate intake but from impaired absorption or utilization.
Dietary sources rich in B12 include beef liver, fortified yeast, salmon, Greek yogurt, eggs and clams. Beef liver contains about 71 micrograms per serving, compared with about 0.5 micrograms in an egg. Recommended daily intake is 2.4 micrograms for adults, increasing to 2.6 micrograms during pregnancy and 2.8 micrograms while breastfeeding.
When comparing supplement forms, the review noted that B12 from either food or supplements must ultimately be converted into the active forms methylcobalamin or adenosylcobalamin. Cyanocobalamin, the most common synthetic supplement form, must first have its cyano group removed before activation, and mutations in metabolic pathways may impair this conversion in some people.
Evidence suggests that cyanocobalamin is stored in the liver at lower levels than natural forms and may be excreted in urine at a higher rate. Inadequate conversion by the liver may adversely affect neurological health. The methyl group carried by methylcobalamin may also promote serotonin production and offer some brain protection. Although current research is not sufficient for definitive conclusions, the overall evidence suggests that methylcobalamin may have better bioavailability and stability than cyanocobalamin, particularly for people with absorption problems or impaired methylation.
The authors emphasized that while both forms can effectively raise serum B12, direct comparative evidence on clinical outcomes remains limited. Future studies should clarify how different supplement forms affect long-term neuroprotection and disease prevention.
The review recommends greater B12 screening among older adults, vegetarians and people with certain gastrointestinal disorders. Early intervention may help prevent irreversible neurological and hematological damage.
Story source:
Collected online